Neodynamics
0,902 SEK +0,22%HC Andersen Capital har tidligere modtaget betaling fra Neodynamics for en Digital IR/Corporate Visibility abonnementsaftale. Hermed kan der være betalt materiale, som ikke er opdateret. Læs mere her.
7 investorer følger denne virksomhed
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Omsætning
320 t
EBIT %
-28.425 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
NEOD
Daglig lav / høj pris
0,9 / 0,95
SEK
Markedsværdi
29,42 mio. SEK
Aktieomsætning
7,58 t SEK
Volumen
8,3 t
Analyst
Claus Thestrup
CEO, Sweden
Seneste videoer
Finanskalender
Delårsrapport
20.08.2024
Delårsrapport
19.11.2024
Årsrapport
17.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Gryningskust Holding AB | 32,9 % | 32,9 % |
Rentability Sweden AB | 4,0 % | 4,0 % |
Premium
This content is for our Premium customers only.
Forum opdateringer
ViserAlle indholdstyper
NeoDynamics applies for delisting
Bulletin from the annual general meeting in NeoDynamics AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools